Form 8-K - Current report:
SEC Accession No. 0001104659-24-083012
Filing Date
2024-07-26
Accepted
2024-07-26 16:01:17
Documents
13
Period of Report
2024-07-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420291d1_8k.htm   iXBRL 8-K 29107
  Complete submission text file 0001104659-24-083012.txt   203844

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA seel-20240725.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20240725_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20240725_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2420291d1_8k_htm.xml XML 3676
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 241146716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)